首页> 外文期刊>Clinical and Experimental Otorhinolaryngology >Association of the Oncostatin M Receptor Gene Polymorphisms with Papillary Thyroid Cancer in the Korean Population
【24h】

Association of the Oncostatin M Receptor Gene Polymorphisms with Papillary Thyroid Cancer in the Korean Population

机译:抑癌素M受体基因多态性与韩国人群的乳头状甲状腺癌的关联。

获取原文
           

摘要

Objectives To investigate the association between papillary thyroid cancer (PTC) and single nucleotide polymorphisms (SNPs) of oncostatin M receptor ( OSMR ) in the Korean population. Methods Retrospective case-control study was done. Eighty-five patients with PTC and 287 controls were studied. One missense SNP (rs2278329, Asp553Asn) and one promoter SNP (rs2292016, -100 G/T) of the OSMR gene were genotyped by direct sequencing. Genetic data were analyzed using the SNPStats, Helixtree, and SNPAnalyzer Pro. PTC patients were dichotomized and compared with respect to the clinicopathologic characteristics. Results There was no association between genotypes and allele frequencies of OSMR SNPs (rs2278329 and rs2292016) and PTC susceptibility. SNP rs2278329 was significantly associated with tumor size (dominant model; P =0.028; odds ratio [OR], 2.71; 95% confidence interval [CI], 1.12 to 6.57). The A allele was higher in sizes large than 1 cm (32.5% vs. 16.7%; P =0.018; OR, 2.41; 95% CI, 1.17 to 4.98). Regarding the number of tumors, we found no significant association with genotype, however, the A allele was higher in patients with multifocaltiy (33.3% vs. 19.1%; P =0.040; OR, 2.12; 95% CI, 1.03 to 4.34). Conclusion The results suggest that OSMR polymorphism rs2278329 is associated with clinicopathologic characteristics of the tumor growth and multifocality development.
机译:目的探讨韩国人群中甲状腺乳头状癌(PTC)与癌抑素M受体(OSMR)的单核苷酸多态性(SNP)之间的关系。方法进行回顾性病例对照研究。研究了八十五名PTC患者和287名对照。通过直接测序对OSMR基因的一个错义SNP(rs2278329,Asp553Asn)和一个启动子SNP(rs2292016,-100 G / T)进行基因分型。使用SNPStats,Helixtree和SNPAnalyzer Pro分析遗传数据。将PTC患者一分为二,并就临床病理特征进行比较。结果OSMR SNP(rs2278329和rs2292016)的基因型和等位基因频率与PTC敏感性之间没有关联。 SNP rs2278329与肿瘤大小显着相关(优势模型; P = 0.028;优势比[OR]为2.71; 95%置信区间[CI]为1.12至6.57)。 A等位基因的大小大于1 cm(32.5%vs. 16.7%; P = 0.018; OR,2.41; 95%CI,1.17至4.98)。关于肿瘤的数量,我们发现与基因型无显着相关性,但是,多焦点患者的A等位基因较高(33.3%比19.1%; P = 0.040; OR,2.12; 95%CI,1.03至4.34)。结论结果提示OSMR多态性rs2278329与肿瘤生长和多灶性发展的临床病理特征有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号